Search

everythinglearnresearchcommunity

for

Search:↓

Skin cells can naturally limit the growth of cancerous changes by balancing cell renewal and differentiation.

The document concludes that the development of certain tumors is influenced by genetic background and that a specific gene modification can lead to tumor regression and reduced growth.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

Some Greek melanoma patients have gene mutations linked to increased cancer risk, a new color feature helps diagnose melanoma, the incidence of a skin condition in the Netherlands is rare, and a gene possibly affects male-pattern baldness.

Myeloid cells can turn into skin and hair cells to help heal wounds.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

Keratin 10 end domains may increase skin cancer risk by reducing cell death.

Granzyme B accelerates skin aging and impairs healing by breaking down important skin components.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Combining topical delgocitinib with a 308-nm excimer laser can effectively treat severe alopecia areata and vitiligo.

The Trichodysplasia spinulosa virus protein can cause abnormal hair growth in mice.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

NCSTN gene mutation causes abnormal skin cell differentiation and more inflammation, contributing to Hidradenitis Suppurativa.

Combining delgocitinib ointment with excimer laser can effectively treat severe alopecia areata.

Normal cells outcompete and remove mutant cells in the pancreas with the help of the EphA2 receptor.

Tofacitinib may help regrow hair in alopecia areata patients.

Blocking CXCL12 can reverse hair loss and fibrosis in androgenetic alopecia.

Overexpressing PKCepsilon in mice reduces papillomas but increases carcinomas.

Mice with extra PKCδ resist chemical-induced skin cancer but not UV-induced.

The gp130 receptor helps in tissue regeneration and disease progression, and manipulating it could improve healing and prevent disease.

Telocytes have potential in therapy and tissue regeneration, but challenges in identification and cultivation remain.

CDK4/6 inhibitors can protect hair cells from chemotherapy damage.

CD271 is crucial for maintaining healthy skin and preventing inflammation.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

FGFR2 signaling controls Merkel cell formation in different skin regions.

Gingerol may help treat chronic graft-versus-host disease by improving immune cell balance.

Bimekizumab effectively treated a man's chronic beard hair loss.